Colgate Palmolive   Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: New York NY United States (1806)
Status: No NME R&D (1806)

Organization Overview

First Clinical Trial
1998
NCT00004640
First Marketed Drug
1994
chlorhexidine (hibitane)
First NDA Approval
1997
triclosan
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Colgate Palmolive | COLGATE PALMOLIVE | COLGATE PALMOLIVE CO | COLGATE-PALMOLIVE CO | Colgate-Palmolive Company

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 3)

Chronic Periodontitis (Phase 4)

Dental Caries (Phase 4)

Dental Plaque (Phase 4)

Dentin Sensitivity (Phase 3)

Gingival Diseases (Phase 3)

Gingivitis (Phase 4)

Hypersensitivity (Phase 3)

Inflammation (Phase 4)

Mucositis (Phase 3)

Peri-Implantitis (Phase 3)

Periodontal Diseases (Phase 4)

Periodontitis (Phase 4)

Tooth Loss (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 58
  • # of Trial APIs: 25